Trial intelligence / Profile preview

Intrauterine ciprofloxacin for chronic endometritis in recurrent implantation failure

IRCT20230111057108N1Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
Feb 2023
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of ciprofloxacin in endometritis, sponsored by Shahrekord University of Medical Sciences. Started Feb 2023; status: completed.

02

Drugs

ciprofloxacin
03

Conditions

endometritis

Beyond the preview

Go deeper on IRCT20230111057108N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230111057108N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call